Navigation Links
NuVasive Acquires First Stem Cell Bone Graft Substitute
Date:5/14/2008

New technologies will drive US bone graft substitute market to reach almost

$1.9 billion by 2012, according to Millennium Research Group

WALTHAM, Mass., May 14 /PRNewswire/ -- With the acquisition of Osiris Therapeutics' Osteocel business, NuVasive has obtained the first off-the-shelf bone graft substitute (BGS) product to incorporate viable stem cells. Mounting surgeon excitement about this new BGS and other innovative products will drive the BGS market to $1.9 billion in 2012, according to Millennium Research Group's US Markets for Orthopedic Biomaterials 2008 report.

"The popularity of advanced BGS technologies has increased competition within the field. Medtronic Spinal and Biologics' INFUSE BGS, based on a recombinant human bone morphogenetic protein, has forced NuVasive and other BGS competitors to dramatically innovate," says Kevin Flewwelling, Orthopedics Research Manager at Millennium Research Group. "In 2007, INFUSE sales exceeded $700 million in the US and NuVasive saw an opportunity to compete against this very successful product."

In order to compete against these advanced BGS, other manufacturers of traditional BGS products -- such as demineralized bone matrices and synthetics -- are developing next-generation products that offer improved ease-of-use and superior bone healing and regrowth. Companies claim that these new features eliminate the need for autograft bone harvested from the patient's iliac crest, reducing postoperative pain and morbidity at the donor site. With these greater advantages, surgeons are shifting towards these newer devices. A survey of surgeons conducted by Millennium Research Group found that 30.3% expected to perform fewer procedures using only autograft bone by 2012.

In addition to the BGS market, the US Markets for Orthopedic Biomaterials 2008 report covers the hyaluronic acid viscosupplementation, machined bone interbody device, knee cartilage repair, and cell concentration system ma
'/>"/>

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
9. NuVasive Reports First Quarter 2008 Financial Results
10. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...27 Shamir Optical Indust...rovider of innovative products and technology to t...s board of directors had declared a dividend distr...approximately NIS 37.62 million based on the Novem...approximately US$ 0.609 (approximately NIS 2.3 bas...
(Date:11/27/2009)...ical, economic burdens, study predicts , ...of people with diabetes in the United States is ex...dy predicts. , That would bring the total by 20...up from 23.7 million today. , , At the same time...riple, the study also warns, rising from an estima...
(Date:11/27/2009)...bilingual coloring books designed for children age...ity to educate - inform parents and children alike...nosuars to ABC,S and a host of other topics. , ...mber 27, 2009 -- Today’s children have enoug...ny hour of the day, but one of the oldest and simp...
(Date:11/26/2009)...e/ -- With cold and flu season upon us, it,s more ...ntrol the spread of infections and avoid illness. ...rselves healthy, but to avoid transmitting illness...(certified in infection-control), nursing director...Hospital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...d that DDT can cause developmental delays in infan... While DDT is currently banned in the United Sta... combat mosquitoes that spread malaria. Accordi... benefits of DDT use to reduce malaria must be con...
...tish tourists face several health risks are riskin... anti malaria pills before they go abroad//. T...ople have visited tropical countries on holiday ov...r cent of British tourists who have visited count...
...sters to approve a progress report on a national p...nancial// help of the federal government to cover ... in Fredericton was planned to be conducted withou...dication of help to pay for the initiative. Acc...
... and scientist are still doing exhaustive research...ope to millions of sick and disabled people that t...world's first clone of an adult mammal. From then ...bryonic stem cell branched out, or differentiated,...
...olved in tumor-suppression or cell-proliferation-s...of pancreatic islet cells, which again affected bl...sity of Pennsylvania School of Medicine reports. ...plications for diabetes treatment. MEN1 patien...
...ith psychological problems into adulthood. A new s...lity of life can be used to learn about the psycho...ntion and treatment. Oral clefting is one o...n experience challenging psychological adjustment ...
Other Medicine News:Health News:Developmental Delays in Infants Linked to DDT 2Health News:Tourists Face Health Risks by Missing Vaccinations 2Health News:Clement Urged to Plot a National Pharmaceutical Strategy 2Health News:Dolly Paves the Way for Exhaustive Stem Cell Research 2Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2
(Date:11/29/2009)...swire/ -- Royal Philips Electronics ( PHG, AEX: PH...d by showing its portfolio of products designed to...meeting of the Radiological Society of North Ameri...are several advancements and upgrades focused on r...eamlining workflow to expand upon clinical capabil...
(Date:11/29/2009)...wire/ -- FUJIFILM Medical Systems USA, Inc., the w...M) with over 7,000 installations, is pleased to de...in the US. The Aspire HD combines the use of adva...eration detector technology and the smallest pixel...solution at a reduced dose for the patient. The f...
(Date:11/29/2009)...e/ -- Researchers using functional magnetic resona...found that men and women respond differently to po...presented today at the annual meeting of the Radio...n may direct more attention to sensory aspects of ...s of implications for required action, whereas wom...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 1Catholics to Rally at USCCB Headquarters in Washington DC Re 3A Healthcare Our Bishops and Abortion 58079 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 1BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 2BioMarin Initiates Phase 2 Clinical Study of PEG PAL in PKU 5031 3Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 1Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 2
...nificant Anti-Tumor Effects of Targeted, Systemic,...n the Limits of,Safe Administrations in Rodent and...007 /PRNewswire/ -- Calando,Pharmaceuticals, a lea...ed subsidiary of Arrowhead Research Corporation,pr...esting in mice,using multiple, systemic dosing wit...
...lif.--(BUSINESS WIRE)--Apr 16, 2007 - Amgen,(Nasda...zed,double-blind, placebo-controlled Phase 3 stud... (darbepoetin alfa) for the,treatment of anemia in...erapy or radiotherapy ("the 103 study"). Aranesp i... patients. These,results were presented in an oral...
Other Medicine Technology:Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 2Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 3Calando Pharmaceuticals Announces Preclinical Efficacy and Safety,Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7
VARIANT II TURBO Hemoglobin Testing System
...ision, ergonomics, and value!, Comfortable feel a... handle , Finer control while pipetting with smoot...avable for easy decontamination and sterilization ...precision micrometer for reproducible, accurate vo...
... 3730 DNA Analyzer, upgradeable to 96 capillaries,...lysis. , Higher optical sensitivity and advance...a at a lower cost. , Multiple automation feature...mers increase your productivity without compromisi...
Pipetman Large-Volume Kit
Medicine Products: